Asia Fresh News

Asia Fresh Stories

Archive for May 25th, 2017

Asia’s Only Dedicated Innovation Summit Returning to Singapore

leave a comment »

-The only show in Asia dedicated purely to innovation as a practice is coming to Singapore on July 4 & 5.
SINGAPORE /PRNewswire/ — The Chief Innovation Officer Summit Singapore will bring together over 120 senior innovation leaders to discuss the practice of innovation in companies across the APAC region and globally.

Representatives from several companies will be discussing innovation across the two-day summit, with some of the organizations involved including AXA, Visa, Dyson, DBS Bank, and Nestle.

The summit will be focused on all elements of innovation, including implementation, empowerment, change management, and cultural change, amongst many others.

“Our aim since the summit was incepted has been to create a collaborative environment where innovation practices can be openly discussed” said summit director Ivy Chen. “I believe that we have been achieving this goal in every year and in every location, we have run the summit. The event in Singapore will be our best yet.”

Amongst those presenting at the summit will be Jim Roovers, Head of Electronics, R&D at Dyson. He will be discussing the story behind one of the world’s most innovative companies, how the 7 million pounds they spend weekly on R&D is used, and what the future of the company holds as they continue to move into other areas. “Having a problem-solving mindset to begin with is important in Dyson. The process of problem-solving can be further honed through hands-on experience developing Dyson products,” said Jim.

The summit will take place on July 4 & 5 at the Grand Copthorne Waterfront Hotel in Singapore.

For more information about the summit, please contact the events manager Ryan Yuan at yuan@theiegroup.com or +852 5808 1636

About Innovation Enterprise

Innovation Enterprise Ltd, a division of Argyle Executive Forum, is a business-to-business media brand specializing in delivering the most innovative business solutions to executive-level decision makers. Innovation Enterprise produces a range on online and offline content, including, but not limited to, summits, online learning, webinars, and white papers, as well as offering other additional services such as lead generation and bespoke research.

Innovation Enterprise focuses on seven key channels – Finance, Supply Chain, Analytics, Big Data, Strategy, Digital, Innovation & Sports – to ensure that organizations are furnished with all the cutting-edge insights necessary to driving growth in the evolving business environment.

SOURCE Innovation Enterprise Ltd.

Source: Innovation Enterprise Ltd.

Written by asiafreshnews

May 25, 2017 at 5:40 pm

Posted in Uncategorized

A. O. Smith, The Water Council partner again to sponsor 2017 BREW Corporate technology challenge

leave a comment »

MILWAUKEE /PRNewswire/ — Once again this year, A. O. Smith Corporation and The Water Council are partnering to identify and support entrepreneurs and start-ups developing innovative freshwater technologies through a global technology challenge, BREW Corporate: Powered by A. O. Smith.

The challenge, which was announced this morning during the 2017 Water Leaders Summit in Milwaukee, will focus on three areas of interest to A. O. Smith:

Water treatment – High-efficiency water treatment technologies to remove contaminants such as trace heavy metals or microbiological materials from drinking water, as well as to improve water aesthetic characteristics including taste, odor and scale formation;
Water heating – High-efficiency, low-emission water heating technologies, most notably durable surface finish concepts, as well as components or systems that prolong the life of a water heater;
Sensors – Cost-effective sensor technologies for continuous or semi-continuous monitoring of trace level contaminants including heavy metals, bacteria and viruses, as well as other water quality indicators including hardness, total organic carbon and pH; and
IoT – Innovative technologies to sense and deliver information for residential and light commercial water applications as well as deliver extended battery life, reduced overall energy consumption, and predictive analytics. Security technologies to protect users’ privacy and manufacturers’ intellectual property.
To be considered, an entrepreneur or start-up must complete an online application that requests basic information about the business, the problem/issue being addressed, and details regarding the company’s stage of technology, core competencies and competitiveness. The deadline for entries is 11:59 p.m. CDT on June 30.

All entries will be reviewed by a panel of A. O. Smith personnel, The Water Council senior staff, and subject matter experts in the area of freshwater science. Recipients will be notified in July; the fall BREW Corporate (Business. Research. Entrepreneurship. In Wisconsin) program begins the week of Sept. 11. For a complete explanation of A. O. Smith’s target technologies, application criteria, and entry forms, go to http://www.globalwaterport.com/brewcorporate.

Recipients will receive a minimum investment of $50,000 from A. O. Smith as well as tuition to participate in The Water Council’s 12-month accelerator program in Milwaukee. In addition to the investment, the winning entrepreneurs receive:

A suite in the Global Water Center for up to 12 months;
Business model and operations training through The Water Council and University of Wisconsin-Whitewater Institute for Water Business;
Access to the Global Water Center’s Flow Lab and A. O. Smith product engineering labs;
Mentorship from A. O. Smith corporate development and senior engineering staff, as well as direct access to BREW Preferred Partners;
Attendance to conferences and pitch sessions with The Water Council; and
A one-year membership to The Water Council providing access to an extensive water technology network.
This is the second year A. O. Smith and The Water Council have sponsored BREW Corporate Technology Challenge. In 2016, A. O. Smith received approximately 20 proposals from water technology companies around the world.

About BREW Accelerator

BREW Accelerator, a program of The Water Council, is a world-class seed accelerator that unleashes water innovation by funding water technology startups from around the world with commercialization potential. The first-of-its-kind accelerator pairs a unique water-focused startup community with credible resources of the World Water Hub to help entrepreneurs accelerate results. Now in its fifth year, BREW has sponsored a total of 25 water technology companies. An expansion of the BREW Accelerator program, BREW Corporate partners with global corporations looking for new technologies to solve a specific challenge.

About A. O. Smith

A. O. Smith Corporation, with headquarters in Milwaukee, Wis., is a global leader applying innovative technology and energy-efficient solutions to products manufactured and marketed worldwide. The company is one of the world’s leading manufacturers of residential and commercial water heating equipment and boilers, as well as a leading manufacturer of water treatment products. For more information, visit http://www.aosmith.com.

About The Water Council

The Water Council was established as a 501(c)(3) organization in 2009 by Milwaukee-area businesses, education and government leaders. With a mission of aligning the regional freshwater research community with water-related industries, the organization takes great pride in having created the leading water technology cluster in the United States and one of the most powerful in the world. Headquartered in the Global Water Center in Milwaukee, Wis., The Water Council links global water technology companies, innovative water entrepreneurs, government agencies, non-governmental organizations, acclaimed academic research programs and some of the nation’s brightest and most energetic water professionals. The driving force behind this success is the spirit of collaboration between public, private and academic sectors and the shared commitment to finding innovative solutions to critical global water issues.

SOURCE A. O. Smith Corporation

Source: A. O. Smith Corporation
Related Links:
http://www.aosmith.com

Written by asiafreshnews

May 25, 2017 at 3:35 pm

Posted in Uncategorized

CLJI Worldwide Trial Enrolls First Patient in Clinical Study Evaluating the Performance of VIBLOK as a Barrier for Herpes Simplex Virus Transmission in Men and Women

leave a comment »

-CLJI Worldwide Sponsored Study Assessing the Safety and Performance of VIBLOK in HSV-2 infected adults as a barrier for virus transmission; Principal Investigators Named; First Patient Enrolled

BAY HARBOR ISLANDS, Florida /PRNewswire/ — CLJI Worldwide reports the start of the VIBLOK Safety And perFormancE Trial (SAFE Trial). The CLJI Worldwide SAFE Trial will evaluate the performance of VIBLOK for adults infected with herpes simplex virus-2 (HSV-2), the cause of genital herpes. VIBLOK is an investigational device developed to help reduce skin-to-skin HSV-2 transmission.

The global burden of HSV-2 is large, leaving over 400 million people living with the infection [1]. Genital lesions due to herpes are often very painful, can lead to substantial psychological morbidity, increase the risk of acquiring HIV [2-8], and can be transmitted from mother to infant during childbirth with potentially serious consequences [9, 10]. There is, however, no treatment eradicating the herpes simplex virus from the body, and disease management focuses on symptom relief, reducing recurrent episodes, and preventing viral transmission between sexual partners. Despite the use of medical treatments and condoms, genital herpes transmission may still occur through unprotected areas of the skin via micro-sized lesions, which are often exacerbated by grooming practices of the genital area, such as shaving and waxing [11].

VIBLOK is a virtually colorless, odorless, and tasteless cream designed to create a protective skin barrier that prevents the passage of viruses (e.g., HSV-2). Laboratory testing indicates that the cream can block virus passage at over 80% efficacy at the correct dosage. The SAFE Trial will provide an indication as to whether VIBLOK can safely and effectively block virus passage from the skin in HSV-2 infected people and in doing so, target the currently high prevalence of this sexually transmitted infection (STI) in industrialized and developing countries.

Dr. Annet Muetstege, PhD, is the clinical project manager, and the coordinating investigator for this clinical trial in The Netherlands is Dr. Vivienne van de Walle, M.D., PhD, CPI from PreCare Trial & Recruitment. The clinical trial strategy and protocol has been developed with help of the Study Steering Committee members Prof. Anna Wald, M.D., MPH at the University of Washington School of Medicine in Seattle, USA, Dr. Annemarie Wensing, M.D., PhD at the Utrecht University in Utrecht, The Netherlands, and Prof. Charles Boucher, M.D., PhD at the Erasmus University, Erasmus Medical Center in Rotterdam, The Netherlands. The prospective, non-randomized, comparative multi-center SAFE Trial is anticipated to last for 12 months in which up to 48 participants with HSV-2 will be enrolled and followed for one month. HSV will be measured from daily self-collected genital swabs before and after the application of VIBLOK.

The investigational centers will include six participating sites in The Netherlands and Germany. As a follow-up to the preclinical tests, this trial is designed to provide further supportive evidence for the efficacy of this skin barrier product to reduce the occurrence of HSV-2 transmission in a clinical setting. EB FlevoResearch in Almere, with Dr. Aletha Veenendaal as its principal investigator, enrolled the first trial participants at the beginning of April.

VIBLOK is an investigational device being evaluated in Europe and the outcomes of this clinical trial will be used to support the product application for CE Mark. It does not have an approved Investigational Device Exemption in the United States.

The clinical trial is being sponsored and managed by CLJI Worldwide which is committed to ’empowering people worldwide to make smart health decisions, and reducing global suffering by protecting them from the physical pain and emotional suffering of preventable diseases.’ CLJI Worldwide was established by Craig Lichtblau, M.D. and Jose Iparraguirre, M.D.; two practicing medical doctors in different specialties, who have been friends for over 30 years. They decided to combine their knowledge with that of a CEO and business leader in order to build an organization that strives to reduce pain and suffering in the world. The SAFE Trial reflects just one of the pioneering studies sponsored by CLJI Worldwide, that aims at investigating overlooked aspects of healthcare and subsequently solving real problems with scientifically and clinically proven products. “We are excited about the start of the SAFE Trial as it represents a significant milestone in our quest to revolutionize STI prevention and ultimately help millions of women and men across the globe live healthier, happier lives” says Ty Cross, President and Chief Executive Officer of CLJI Worldwide.

References

Looker KJ et al. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015 Jan 21;10(1):e114989. doi: 10.1371/journal.pone.0114989.
Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002; 185: 45-52.
Strick LB, Wald A, Celum C. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Clin Infect Dis. 2006; 43: 347-56.
Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004; 82: 447-53.
Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis. 2003; 188: 1492-7.
Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006; 20: 73-83.
Reynolds SJ, Quinn TC. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. Infect Dis Clin North Am 2005; 19: 415-25.
Reynolds SJ. The role of HSV-2 suppressive therapy for HIV prevention. Future Microbiol. 2009; 4: 1095–1097.
Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997; 337: 509-15.
Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes2004; 11: 175A-86A.
Osterberg EC et al. Correlation between pubic hair grooming and STIs: results from a nationally representative probability sample. Sex Transm Infect 2016;0:1–5. doi:10.1136/sextrans-2016-052687

SOURCE CLJI Worldwide

Source: CLJI Worldwide

Written by asiafreshnews

May 25, 2017 at 3:03 pm

Posted in Uncategorized